You are here

Constellation Pharmaceuticals

MorphoSys cuts R&D from Constellation deal to focus on clinical-stage cancer drugs

MedCity News

Fri, 03/11/22 - 10:42 am

Constellation Pharmaceuticals

Biopharma takeovers dry up

EP Vantage

Mon, 07/5/21 - 09:50 pm

Constellation Pharmaceuticals

Tidal Therapeutics

Corlieve Therapeutics

Strongbridge Biopharma

Xerix Pharmaceuticals

Novellus Therapeutics

Brooklyn Immunotherapeutics

Morphosys to buy Constellation in $1.7B deal, aided by unusual funding

BioPharma Dive

Wed, 06/2/21 - 12:10 pm

Constellation Pharmaceuticals

With Roche in the rearview mirror, Constellation Pharma grabs $55M round

Fierce Biotech

Thu, 12/10/15 - 09:49 am

Constellation Pharmaceuticals

venture capital

Dumped by Roche, Constellation Pharma scrambles to join IPO queue

Fierce Biotech

Tue, 08/25/15 - 08:55 am

Constellation Pharmaceuticals

Exclusive: Constellation chops staff, plots go-it-alone strategy as Genentech option deadline looms

Fierce Biotech

Mon, 01/19/15 - 10:31 am

Constellation Pharmaceuticals

Constellation Pharma takes different route than rival in hot epigenetics field

Fierce Biotech

Fri, 06/17/11 - 12:36 pm

Constellation Pharmaceuticals